Literature DB >> 22093304

Microfluidics enables small-scale tissue-based drug metabolism studies with scarce human tissue.

Paul M van Midwoud1, Marjolijn T Merema, Elisabeth Verpoorte, Geny M M Groothuis.   

Abstract

Early information on the metabolism and toxicity properties of new drug candidates is crucial for selecting the right candidates for further development. Preclinical trials rely on cell-based in vitro tests and animal studies to characterize the in vivo behavior of drug candidates, although neither are ideal predictors of drug behavior in humans. Improving in vitro systems for preclinical studies both from a technological and biological model standpoint thus remains a major challenge. This article describes how microfluidics can be exploited to come closer to this goal in combination with precision-cut liver slices (PCLS) as an improved organomimetic system. Recently, we developed a novel microfluidic-based system incorporating a microchamber for slice perifusion to perform drug metabolism studies with mammalian PCLS under continuous flow. In the present study, the viability and metabolism of human PCLS were assessed by the measurement of the leakage of liver-specific enzymes and metabolism of four different substrates: lidocaine, 7-hydroxycoumarin, 7-ethoxycoumarin, and testosterone. All experiments were verified with well plates, an excellent benchmark for these experiments. Clearly, however, human tissue is not readily available, and it is worth considering how to perform a maximum number of informative experiments with small amounts of material. In one approach, the microfluidic system was coupled to an HPLC system to allow on-line monitoring and immediate detection of unstable metabolites, something that is generally not possible with conventional well-plate systems. This novel microfluidic system also enables the in vitro measurement of interorgan interactions by connecting microchambers containing different organ slices in series for sequential perfusion. This versatile experimental system has the potential to yield more information about the metabolic profiles of new drug candidates in human and animal tissues in an early stage of development compared with well plates alone.
Copyright © 2011 Society for Laboratory Automation and Screening. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22093304     DOI: 10.1016/j.jala.2011.07.003

Source DB:  PubMed          Journal:  J Lab Autom        ISSN: 2211-0682


  9 in total

Review 1.  Biomaterial delivery of morphogens to mimic the natural healing cascade in bone.

Authors:  Manav Mehta; Katharina Schmidt-Bleek; Georg N Duda; David J Mooney
Journal:  Adv Drug Deliv Rev       Date:  2012-05-22       Impact factor: 15.470

Review 2.  Bioreactor technologies to support liver function in vitro.

Authors:  Mohammad R Ebrahimkhani; Jaclyn A Shepard Neiman; Micha Sam B Raredon; David J Hughes; Linda G Griffith
Journal:  Adv Drug Deliv Rev       Date:  2014-03-05       Impact factor: 15.470

Review 3.  Biomaterials for Bioprinting Microvasculature.

Authors:  Ryan W Barrs; Jia Jia; Sophia E Silver; Michael Yost; Ying Mei
Journal:  Chem Rev       Date:  2020-09-01       Impact factor: 60.622

Review 4.  Challenges and Opportunities in the Design of Liver-on-Chip Microdevices.

Authors:  Avner Ehrlich; Daniel Duche; Gladys Ouedraogo; Yaakov Nahmias
Journal:  Annu Rev Biomed Eng       Date:  2019-06-04       Impact factor: 9.590

Review 5.  MatriGrid® Based Biological Morphologies: Tools for 3D Cell Culturing.

Authors:  Patrick Mai; Jörg Hampl; Martin Baca; Dana Brauer; Sukhdeep Singh; Frank Weise; Justyna Borowiec; André Schmidt; Johanna Merle Küstner; Maren Klett; Michael Gebinoga; Insa S Schroeder; Udo R Markert; Felix Glahn; Berit Schumann; Diana Eckstein; Andreas Schober
Journal:  Bioengineering (Basel)       Date:  2022-05-20

Review 6.  Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME.

Authors:  Patricio Godoy; Nicola J Hewitt; Ute Albrecht; Melvin E Andersen; Nariman Ansari; Sudin Bhattacharya; Johannes Georg Bode; Jennifer Bolleyn; Christoph Borner; Jan Böttger; Albert Braeuning; Robert A Budinsky; Britta Burkhardt; Neil R Cameron; Giovanni Camussi; Chong-Su Cho; Yun-Jaie Choi; J Craig Rowlands; Uta Dahmen; Georg Damm; Olaf Dirsch; María Teresa Donato; Jian Dong; Steven Dooley; Dirk Drasdo; Rowena Eakins; Karine Sá Ferreira; Valentina Fonsato; Joanna Fraczek; Rolf Gebhardt; Andrew Gibson; Matthias Glanemann; Chris E P Goldring; María José Gómez-Lechón; Geny M M Groothuis; Lena Gustavsson; Christelle Guyot; David Hallifax; Seddik Hammad; Adam Hayward; Dieter Häussinger; Claus Hellerbrand; Philip Hewitt; Stefan Hoehme; Hermann-Georg Holzhütter; J Brian Houston; Jens Hrach; Kiyomi Ito; Hartmut Jaeschke; Verena Keitel; Jens M Kelm; B Kevin Park; Claus Kordes; Gerd A Kullak-Ublick; Edward L LeCluyse; Peng Lu; Jennifer Luebke-Wheeler; Anna Lutz; Daniel J Maltman; Madlen Matz-Soja; Patrick McMullen; Irmgard Merfort; Simon Messner; Christoph Meyer; Jessica Mwinyi; Dean J Naisbitt; Andreas K Nussler; Peter Olinga; Francesco Pampaloni; Jingbo Pi; Linda Pluta; Stefan A Przyborski; Anup Ramachandran; Vera Rogiers; Cliff Rowe; Celine Schelcher; Kathrin Schmich; Michael Schwarz; Bijay Singh; Ernst H K Stelzer; Bruno Stieger; Regina Stöber; Yuichi Sugiyama; Ciro Tetta; Wolfgang E Thasler; Tamara Vanhaecke; Mathieu Vinken; Thomas S Weiss; Agata Widera; Courtney G Woods; Jinghai James Xu; Kathy M Yarborough; Jan G Hengstler
Journal:  Arch Toxicol       Date:  2013-08-23       Impact factor: 5.153

Review 7.  Advances in Engineered Liver Models for Investigating Drug-Induced Liver Injury.

Authors:  Christine Lin; Salman R Khetani
Journal:  Biomed Res Int       Date:  2016-09-20       Impact factor: 3.411

8.  Differentiation of human-induced pluripotent stem cell under flow conditions to mature hepatocytes for liver tissue engineering.

Authors:  Viktoriia Starokozhko; Mette Hemmingsen; Layla Larsen; Soumyaranjan Mohanty; Marjolijn Merema; Rodrigo C Pimentel; Anders Wolff; Jenny Emnéus; Anders Aspegren; Geny Groothuis; Martin Dufva
Journal:  J Tissue Eng Regen Med       Date:  2018-04-06       Impact factor: 3.963

9.  Maintenance of head and neck tumor on-chip: gateway to personalized treatment?

Authors:  Ruth Bower; Victoria L Green; Elena Kuvshinova; Dmitriy Kuvshinov; Laszlo Karsai; Stephen T Crank; Nicholas D Stafford; John Greenman
Journal:  Future Sci OA       Date:  2017-03-07
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.